UNSPSC 41171503: Fully automated short-term incubation cycle antimicrobial susceptibility system

In this classification a fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens.

Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases US FDA regulates Fully automated short-term incubation cycle antimicrobial susceptibility system under 21 CFR 866.1645 and under FDA product code LON.

UNSPSC 41171503 Fully automated short-term incubation cycle antimicrobial susceptibility system is a Commodity code covering laboratory instruments that perform rapid bacterial culture and drug-sensitivity testing in a single automated workflow. State and local health departments, hospitals, and clinical laboratory networks use these systems to identify pathogenic bacteria and their resistance profiles in hours rather than days, enabling faster clinical decision-making and infection control. The systems integrate culture initiation, incubation, and susceptibility reporting without manual transfers between stages, reducing hands-on labor and cross-contamination risk in high-volume diagnostic settings.

The source provided contains no recent state or local contract opportunities for this Commodity code. Without posted solicitations, scope specifications, issuing-body patterns, or geographic activity data, no purchasing trends or market signals can be derived. Organizations evaluating whether to pursue business under this code should monitor state health department procurement channels, hospital system RFPs, and clinical laboratory cooperative purchasing groups for future opportunities.